Edwards Lifesciences (NYSE:EW) today unveiled its “Stay in the Race” initiative to support heart valve health.

Artificial heart valves can sustain life for cardiovascular patients. They play a similar role for Edwards Lifesciences Corp. Growing heart valve profits coupled with the shedding of slow-growth ...

Edwards Lifesciences Corp. still is the king of heart valves. But it has to defend its throne this year. The Irvine-based company is the No. 1 heart valve maker with 40% of the overall market and a 60 ...

The Food and Drug Administration approved a new use for Edwards Lifesciences Corp.’s Sapien 3 artificial heart valve, reports Reuters. The valve may now be used to replace failing heart valves ...

Medtronic scored a badly needed point in its heart valve struggles with rival Edwards Lifesciences when the European Patent Office (EPO; The Hague) ruled that Edwards' so-called Spenser patent was ...

WASHINGTON (AP) — The Food and Drug Administration said Monday that it has approved broader use of an innovative artificial heart valve that can be implanted without major surgery, allowing surgeons ...

Edwards Lifesciences has claimed the FDA’s first approval of a transcatheter replacement implant for a leaky tricuspid heart valve, three months after garnering a green light in Europe. The Evoque, ...

NEWBURY, England--(BUSINESS WIRE)--Edwards Lifesciences announced new data from the COMMENCE aortic trial, demonstrating low rates of structural valve deterioration (SVD) in bioprosthetic aortic ...